C4 Therapeutics Appoints Steve Hoerter to Board
The latest update is out from C4 Therapeutics ( (CCCC) ).
Seeking Alpha18d
C4 Therapeutics: Holding Fast To A Generous Valuation Heading Into An Important ASH Readout
CCCC has also guided that they expect the dose ... Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate ...
Analysts Set C4 Therapeutics, Inc. (NASDAQ:CCCC) Price Target at $10.50
Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) have received an average rating of “Hold” from the five ...
Fintel on MSN5d
Stephens & Co. Initiates Coverage of C4 Therapeutics (CCCC) with Equal-Weight Recommendation
Fintel reports that on November 18, 2024, Stephens & Co. initiated coverage of C4 Therapeutics (NasdaqGS:CCCC) with a ...
Wall Street Journal9d
CCCC Design Consulting Group Co. Ltd. A
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
MarketWatch12d
Carrier Global Corp. stock underperforms Monday when compared to competitors
Shares of Carrier Global Corp. CARR slipped 0.51% to $76.29 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.10% to ...